{"id":"201","presentation":"303 - Association between Angiotensin II Antagonism and Mortality after LVAD Implantation: A Multi-Center, Contemporary Analysis","session":"SESSION 77 - ORAL: Optimal Drug Therapy and Monitoring of MCS Patients","filename":"ACE_ARB Mortality Multicenter.pptx","speaker":"J. Schultz<small>, Minneapolis, MN, United States of America<\/small>","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ishlt40th\/201\/jpg\/ace_arbmortalitymulticenter\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E6671\/session_token\/879a40922646148c6ba369cdf2a34f90","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]